Inventor · disambiguated record

Xiquan Zhang

Also filed as: ZHANG XIQUAN

48 granted patents·32 pending applications·52 citations·filing 2010–2025

96Inventor score

Technology areasA61P A61K C07K C07D C07B

Files withCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD66 HUAWEI TECH CO LTD5 NANJING SHUNXIN PHARMACEUTICALS CO LTD OF CHIATAI TIANQING PHARMACEUTICAL GROUP3 ZHANG AIMING2 CENTAURUS BIOPHARMA CO LTD1

Top patents by PatentIndex Score

80 records

0191US9968597B2Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted May 15, 2018·13 cites·20 claims
0289US10183017B2Methods and uses of quinoline derivatives in the treatment of soft tissue sarcomas and pharmaceutical compositions for treatment of sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted Jan 22, 2019·9 cites·20 claims
0388US11419862B2Quinoline derivative for treatment of nasopharyngeal carcinomaCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Aug 23, 2022·3 cites·22 claims
0485US12319689B2Methyl- and trifluoromethyl-containing disubstituted sulfonamide selective BCL-2 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Jun 3, 2025·2 cites·20 claims
0585US11554115B2Quinoline derivative for treatment of triple-negative breast cancerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Jan 17, 2023·2 cites·20 claims
0684US10562904B2Synthesis process of ruxolitinibCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Feb 18, 2020·8 cites·20 claims
0783US10766901B2Preparation method for chiral pyrrolopyrimidine compoundCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Sep 8, 2020·3 cites·20 claims
0881US11332465B2Diarylthiohydantoin compound as androgen receptor antagonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted May 17, 2022·3 cites·20 claims
0979US10745383B21,3,5-triazine derivative and method of using sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Aug 18, 2020·2 cites·15 claims
1079US10626107B2Crystal form, salt type of substituted 2-hydro-pyrazole derivative and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Apr 21, 2020·2 cites·16 claims
1173US12390458B2Therapeutic combination of quinoline derivative and antibodyCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Aug 19, 2025·1 cites·14 claims
1273US11014943B2Azetidine derivativeCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2018·Granted May 25, 2021·1 cites·20 claims
1370US10231973B2Salts of quinazoline derivative and method for preparing the sameCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Mar 19, 2019·1 cites·14 claims
1467US10035792B2Resorcinol derivative as HSP90 inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Jul 31, 2018·1 cites·20 claims
1567US9981946B2Pyridine-substituted 2-aminopyridine protein kinase inhibitorsCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2015·Granted May 29, 2018·1 cites·20 claims
1666US11866433B2Diarylthiohydantoin compound as androgen receptor antagonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Granted Jan 9, 2024·0 cites·20 claims
1764US11534398B2Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseasesCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Dec 27, 2022·0 cites·10 claims
1864US2025282873A1Drug combination of anti-tim-3 antibody and anti-pd-1 antibodyNANJING SHUNXIN PHARMACEUTICALS CO LTD OF CHIATAI TIANQING PHARMACEUTICAL GROUP·Filed 2023·Application pending·0 cites
1961US2025034165A1Compound containing cycloalkyl or haloalkylCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
2061US2025295765A1Drug combination for treating non-small cell lung cancerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
2161US2024398942A1Use of anti-cd40 antibodyCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
2261US2025257064A1Trifluoromethyl-substituted sulfonamide as bcl-2-selective inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2025·Application pending·0 cites
2360US12508258B2Quinoline derivative for treating rheumatoid arthritisCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Granted Dec 30, 2025·0 cites·13 claims
2460US12447154B2Use of pyrrolopyrimidine compound for treating hemophagocytic syndromeCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Granted Oct 21, 2025·0 cites·20 claims
2560US2024343807A1Pharmaceutical composition for treating small cell lung cancerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
2660US2024269278A1Anti-cd47 antibody for combined treatment of blood tumorNANJING SHUNXIN PHARMACEUTICALS CO LTD OF CHIATAI TIANQING PHARMACEUTICAL GROUP·Filed 2022·Application pending·0 cites
2759US12231186B2Method and apparatus for generating physical network topologyHUAWEI TECH CO LTD·Filed 2022·Granted Feb 18, 2025·0 cites·20 claims
2859US2025223347A1Antigen binding constructs targeting her2 and uses thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2025·Application pending·0 cites
2958US2024285635A1Use of pyrrolopyrimidine compound and pharmaceutical composition thereof for treating chronic graft versus host diseaseCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
3058US2023242632A1Antigen binding constructs targeting her2 and uses thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
3157US2020338519A1Method for preparing liposomeCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
3256US11292809B2Crystals of glycyrrhizic acid derivatives, crystalline compositions, pharmaceutical compositions and uses thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Apr 5, 2022·0 cites·20 claims
3356US10626118B2Pyrrolopyrimidine crystal for preparing JAK inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Granted Apr 21, 2020·0 cites·20 claims
3456US2020361908A1Crystals of aniline pyrimidine compound serving as egfr inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Application pending·0 cites
3555US2023310596A1Drug for treating tumorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
3655US2023227556A1Combination drug for treating kidney cancerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
3755US2024043401A1Salt form of tetra-substituted olefin compound, crystal, and preparation method thereforCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
3854US2024374593A1Combined pharmaceutical composition of cdk4/6 inhibitor and aromatase inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
3954US2023263795A1Combined pharmaceutical composition of c-met kinase inhibitor and anti-pd-l1 antibodyCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
4053US11881931B2Data transmission time obtaining method, apparatus, and systemHUAWEI TECH CO LTD·Filed 2022·Granted Jan 23, 2024·0 cites·17 claims
4153US2019117568A1Inhaled Preparation Of Isoglycyrrhizic Acid Or Salt Thereof, And Use In Preparing Drugs For Treating Respiratory System DiseasesCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2017·Application pending·0 cites
4253US2023272086A1St2 antigen binding proteinCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
4352US12371431B2Trifluoromethyl-substituted sulfonamide as BCL-2-selective inhibitorCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Jul 29, 2025·0 cites·20 claims
4452US2024139208A1Combined pharmaceutical composition containing cdk4/6 inhibitor and use thereofCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2022·Application pending·0 cites
4551US12336996B2Drug combination containing TLR7 agonistCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2020·Granted Jun 24, 2025·0 cites·19 claims
4651US12128047B2TLR7 agonist and pharmaceutical combination thereof for treating lung cancerCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Oct 29, 2024·0 cites·15 claims
4750US11702439B2Method for preparing trifluridineCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2019·Granted Jul 18, 2023·0 cites·19 claims
4850US2023119759A1Pharmaceutical combination comprising pyridino[1,2-a]pyrimidinone compoundCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
4950US2023235057A1Bifunctional protein against pd-1 and tgf-betaCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2021·Application pending·0 cites
5049US10385038B2Pyridine substituted 2-aminopyridine protein kinase inhibitor crystalCHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD·Filed 2016·Granted Aug 20, 2019·0 cites·11 claims

Showing the top 50 of 80 patent records by PatentIndex Score.

Join the waitlist — get patent alerts

Get an alert when Xiquan Zhang files or is granted a new patent.

We store only your email — no account needed. See our privacy policy.

Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →